Skip to main content

Find Clinical Trials

Home
Conditions
Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis

Clinical trial condition

Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis

Explore clinical trials studying Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis trial results

Recruiting

Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis

NCT07488728

Conditions: EBV-associated T/NK-cell Lymphoproliferative Diseases, Letermovir, Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis
Locations: Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details